Loading...

Healthcare Trust of America, Inc.

HTANYSE
Real EstateREIT - Healthcare Facilities
$29.19
$-0.02(-0.07%)

Healthcare Trust of America, Inc. HTA Peers

See (HTA) competitors and their performances in Stock Market.

Stock Comparison

Select a stock to compare (requires JavaScript). Showing default comparison.

HTA vs WELL Comparison

HTA plays a significant role within the Real Estate sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, HTA stands at 11.11B. In comparison, WELL has a market cap of 97.53B. Regarding current trading prices, HTA is priced at $29.19, while WELL trades at $149.14.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

HTA currently has a P/E ratio of 69.50, whereas WELL's P/E ratio is 84.74. In terms of profitability, HTA's ROE is +0.00%, compared to WELL's ROE of +0.03%. Regarding short-term risk, HTA is more volatile compared to WELL. This indicates potentially higher risk in terms of short-term price fluctuations for HTA.

Loading...

Peer Comparison Table: REIT - Healthcare Facilities Industry

Detailed financial metrics including price, market cap, P/E ratio, and more.

SymbolPriceChange %Market CapP/E RatioEPSDividend Yield
WELL$149.14+0.60%97.53B84.74$1.76+1.75%
VTR$66.00+0.64%29.79B200.00$0.33+2.77%
DOC$17.48+0.49%12.49B42.62$0.41+5.75%
HTA$29.19-0.07%11.11B69.50$0.42N/A
OHI$35.88+0.93%10.38B22.29$1.61+7.46%
PEAK$17.10+2.09%9.36B31.09$0.55+5.75%
CTRE$29.15+0.69%5.59B31.34$0.93+4.12%
AHR$34.91+8.38%5.54B-120.38-$0.29+2.86%
HR$15.36+0.23%5.40B-13.71-$1.12+8.07%
SBRA$18.19+1.73%4.33B30.32$0.60+6.58%
Showing 1 to 10 of 33 results
1

Frequently Asked Questions

Meyka LogoMeyka

Meyka is the best Alternative Data platform powered by AI providing research insights for investors

Connect With Us

Legal Disclaimer

The information provided by Meyka AI PTY LTD is for informational and research purposes only and does not constitute financial, investment, or trading advice. Meyka is a research platform, not a financial advisory service. Investing in financial markets involves risks, and past performance does not guarantee future results. Users should conduct their own due diligence, consult with professional financial advisors, and assess their risk tolerance before making investment decisions. Meyka and its operators are not liable for any financial losses incurred from the use of information on this platform. The data provided is derived from publicly available sources and is believed to be reliable but may not always be accurate or up to date. Users should independently verify information and not rely solely on Meyka for financial decisions. By using Meyka, you acknowledge that it does not provide financial advice or recommendations and agree to seek guidance from a qualified financial professional before making any investment decisions.

© 2025 Meyka AI PTY LTD. All rights reserved.